Filing Details
- Accession Number:
- 0000899243-19-029765
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-20 16:32:55
- Reporting Period:
- 2019-12-18
- Accepted Time:
- 2019-12-20 16:32:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1731831 | Eidos Therapeutics Inc. | EIDX | Pharmaceutical Preparations (2834) | 463733671 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1742587 | Uma Sinha | C/O Eidos Therapeutics, Inc. 101 Montgomery Street, Suite 2000 San Francisco CA 94104 | Chief Scientific Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-12-18 | 9,973 | $61.61 | 333,608 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-12-18 | 825 | $62.49 | 332,783 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-12-18 | 1,702 | $63.31 | 331,081 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the weighted average sale price of the shares sold from $61.085 to $62.075 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all sales reported in footnotes 1 through 3.
- Represents the weighted average sale price of the shares sold from $62.08 to $63.075 per share
- Represents the weighted average sale price of the shares sold from $63.10 to $63.785 per share.
Billionaire Hedge Funds
